CompletedPhase 2

Bisphosphonates and Impaction Grafting in Hip Revision

Sweden32 participantsStarted 2008-03

Plain-language summary

The primary focus of this study is to investigate whether increased bone density of the graft in revision arthroplasty of the hip can cause a decreased micromotion of the implant relative to the femur.

Who can participate

Age range45 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with aseptic loosening and osteolysis scheduled for hip revision using allograft and impaction technique * Obtained informed consent * Pregnancy excluded in women of childbearing age Exclusion Criteria: * Patients with known renal disease or S-creatinine \>175 mcmol/L * Patients with S-calcium 2.75 mmol/L * Patients with diagnosed Rheumatoid arthritis * Patients with active primary hyperparathyroidism

What they're measuring

Decrease of prosthetic micromotion from 2.7 mm to 1.7 mm as measured by RSA (0-24 months)

Timeframe: 12 months

Trial details

NCT IDNCT00658268

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08-01

View on ClinicalTrials.gov More Aseptic Loosening of the Hip Prosthesis trials